Recap: Michael R. Harrison Innovation Symposium

The UCSF Pediatric Surgery and Fetal Treatment Center, in collaboration with UCSF-Stanford Pediatric Device Consortium hosted the 4th Annual Michael R Harrison Innovation Symposium on Friday, October 7, 2022 at UCSF Mission Bay Conference Center. More than 200 participated in this symposium onsite and virtually!

The PDC/SI team with the grant winners!

Event Details

The symposium was kicked off with a warm welcome from Dr. Hanmin Lee (Professor and Chief of UCSF Pediatric Surgery) and by Opening Remarks from Dr. Daniel Lowenstein (Provost and Executive Vice Chancellor, UCSF). The morning session was focused on device innovation and featured the UCSF-Stanford PDC Pitch Competition in which 11 teams pitched their pediatric device innovations, to an esteemed panel of judges, to win one of the PDC awards (from a total pool of $300,000).

This was followed by a Pediatric Device Innovators Forum on ‘Unique Device Identifiers (UDI)’, which started off with a keynote about bolstering health equity for pediatric patients presented by Harvard’s Dr. Florence Bourgeois; followed by a panel discussion in which panelists from PDC, FDA and leading academic and healthcare institutions delved into perspectives from supply chain, value committees, and academic research. This panel later pivoted to a discussion about the challenges and opportunities for UDI Uptake and a very active Q&A session.

The afternoon session was kicked off with a spirited showcase of the UCSF Pediatric Surgery initiatives on global health, equity, disaster management and regenerative medicine, opening up the floor to questions from the audience. Furthermore, following a riveting keynote address by Stanford’s own Dr. Michael Longaker (Professor and Vice Chair of Surgery) on novel ways for scarless wound healing, two more discussion panels introduced experiences from UCSF’s biodevice innovation pathway program for surgical residents and advances made in ECMO and artificial placenta research, respectively. Finally, we wrapped up the day with an award ceremony for the Pitch winners by Dr. Michael Harrison and closing remarks.

Presentation from Dr. Michael Longaker of Stanford University

We would like to thank all symposium participants including pitch finalists, judges, keynote speakers, panelists, moderators, organizers and all attendees for making this a great learning experience. We hope to see you all back next year for the Symposium!

PDC Pitch Competition 2022 Winners List

We are excited to announce the winners of the UCSF Benioff Children’s Hospitals Award, Platinum, Gold, and silver Awards at our UCSF-Stanford PDC Accelerator Pitch Competition on October 7, 2022. Thank you for your commitment to innovating for children's health.

Congratulations to all finalists on their awards!

PLATINUM AWARD- $100,000

Auctus Surgical Inc. – Dynamic Vertebral Body Tethering System

GOLD AWARDS- $50,000 each

Navi Medical Technologies Inc. - The Neonav

Stanford University School of Medicine - Vortex Shunt

SILVER AWARDS- $25,000 each

Lighthanded Enterprises LLC - LasEar

Neonatal Rescue - Neolife Ventilator

Stork Labs & UC Santa Cruz - Pelican

Myka Labs & UC San Francisco - Elect

New pain management therapy cleared for use in adolescents thanks to a groundbreaking collaboration between the UCSF-Stanford PDC, AtriCure, Inc., and the U.S. FDA

A new pain management therapy has been cleared for use in adolescents thanks to a groundbreaking collaboration between the UCSF-Stanford Pediatric Device Consortium (PDC), AtriCure, Inc., and the U.S. Food and Drug Administration (FDA).

On January 4th, AtriCure announced that the FDA cleared its cryo nerve block (cryoNB) devices cryoICE ® and cryoSPHERE™ for post-operative pain management in patients aged 12 and above. The expanded claims were allowed based on real-world evidence (RWE) developed by researchers at the PDC. RWE is an emerging area of regulatory science where evidence derived from real-world data (captured outside of traditional clinical trial settings) is used to evaluate the potential risks and benefits of a device or drug and inform regulatory decision making.

Research Team Awarded Grant for Novel Medical Device to Treat Recurrent Stomal Prolapse

Research Team Awarded Grant for Novel Medical Device to Treat Recurrent Stomal Prolapse

A research team including UCSF pediatric surgeons Dr. Olajire Idowu and Dr. Sunghoon Kim has been awarded a grant to support commercialization of the "Prolapse Whisperer", a novel medical device to treat and prevent recurrent stomal prolapse. Stomal prolapse occurs when the bowel near the stoma, a surgically created intestinal opening, intussuscepts from within causing possible bowel obstruction and ischemia (restriction in blood supply to tissues). Current treatments include manual reduction by force or a surgical procedure. Unfortunately, neither is durable and additional recurrences are common.

The Kidney Project earns KidneyX award to make home dialysis better for patients

The Kidney Project earns KidneyX award to make home dialysis better for patients

A team of researchers from UC San Francisco, Vanderbilt University Medical School (VUMC), and Silicon Kidney are among the winners of the “KidneyX: Redesign Dialysis” prize competition for their design of an innovative, implantable hemofilter dialysis system that would enable patients to safely and effectively treat kidney failure at home.

Stanford and UCSF Award Seed Funding to Top Device Developers at Pediatric Device Accelerator Pitch Competition

Stanford and UCSF Award Seed Funding to Top Device Developers at Pediatric Device Accelerator Pitch Competition

Stanford Children's Health announced the winners of the pediatric medical device development competition hosted by the UCSF-Stanford Pediatric Device Consortium (PDC). […] In a timed, Shark Tank–style presentation, 13 finalists from a total of 74 applicants pitched their pediatric device ideas—in various stages of development—to a panel of judges.